E11.620
Type 2 diabetes mellitus with diabetic dermatitis
Clinical Classification Guidelines
Inclusion Terms
- Type 2 diabetes mellitus with diabetic necrobiosis lipoidica
Medical Intelligence & Overview
Type 2 diabetes mellitus is a chronic condition that affects the way the body processes blood sugar (glucose). When this condition is accompanied by diabetic dermatitis, it often involves skin-related complications caused by long-standing high blood sugar. One common form of diabetic dermatitis is necrobiosis lipoidica, a skin condition that can lead to shiny, yellowish patches usually found on the lower legs. Recognizing and understanding these skin manifestations can help manage the overall health impact of diabetes.
Causes & Symptoms
Clinical Causes: Persistent high blood sugar levels impair blood flow and weaken blood vessels, leading to skin changes. Poorly controlled diabetes can cause immune system impairments, making the skin more susceptible to infections and inflammatory skin conditions. Diabetic dermatitis, including necrobiosis lipoidica, is thought to result from microvascular damage and alterations in collagen production caused by diabetes. Genetic predisposition and environmental factors may also increase the risk of developing skin complications among diabetics.
Key Symptoms: Shiny, yellowish-brown patches often appearing on the shins, but can also occur on other parts of the legs or body. Lesions that may become ulcerated or open sores if severe or poorly managed. Skin that feels thick, atrophic, or slightly raised around the patches. In some cases, the affected skin may be painful or itchy. Possible changes in skin color, including redness or darker pigmentation around the patches.
Diagnostic & Treatment
Diagnosis Path: Diagnosing diabetic dermatitis typically involves a thorough clinical examination by a healthcare provider, who will assess skin lesions and review medical history. Confirmation may include skin biopsies to identify characteristic tissue changes associated with necrobiosis lipoidica. Blood tests to monitor blood sugar levels are also essential to evaluate the control of diabetes and its contribution to skin issues.
Treatment Protocols: Managing diabetic dermatitis involves both controlling blood sugar levels and specific skin care strategies:
Clinical Advice & FAQs
Billing Guidance
Is E11.620 a billable ICD-10 code?
Yes, E11.620 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E11.620?
Clinical documentation must specify the nature of Type 2 diabetes mellitus with diabetic dermatitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference